TriSalus Life Sciences designs, manufactures, and commercializes innovative medical delivery devices and immunotherapies specifically engineered to treat liver and pancreatic cancers. Its core engineering focus centers on Pressure-Enabled Drug Delivery (PEDD) platforms, which overcome high interstitial fluid pressure inside solid tumors to optimize regional therapeutic delivery and treatment efficacy.